307 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Is Genome Editing the Next Biotech Breakthrough? http://www.zacks.com/commentary/164268/is-genome-editing-the-next-biotech-breakthrough?cid=CS-ZC--164268 May 24, 2018 - Is Genome Editing the Next Biotech Breakthrough?
Avalara Files To Raise $150 Million In U.S. IPO https://seekingalpha.com/article/4175073-avalara-files-raise-150-million-u-s-ipo?source=feed_tag_ipo_analysis May 17, 2018 - Avalara intends to raise $150 million in an IPO of its common stock.The firm provides a range of tax compliance solutions to businesses of all sizes.Topline revenue is growing and its revenue retentio
The Zacks Analyst Blog Highlights: General Dynamics, Enbridge, CSX, Humana and Vertex http://www.zacks.com/stock/news/303768/the-zacks-analyst-blog-highlights-general-dynamics-enbridge-csx-humana-and-vertex?cid=CS-ZC-FT-303768 May 16, 2018 - The Zacks Analyst Blog Highlights: General Dynamics, Enbridge, CSX, Humana and Vertex
Top Research Reports for General Dynamics, Enbridge & CSX Corporation http://www.zacks.com/research-daily/162381/top-research-reports-for-general-dynamics-enbridge-csx-corporation?cid=CS-ZC-FT-162381 May 15, 2018 - Top Research Reports for General Dynamics, Enbridge & CSX Corporation
Drug Prices Too High? Don’t Blame Rebates. Blame the FDA Approval Process http://www.gurufocus.com/news/679791/drug-prices-too-high-dont-blame-rebates-blame-the-fda-approval-process May 10, 2018 - Drug Prices Too High? Don’t Blame Rebates. Blame the FDA Approval Process, Stocks: ESRX,VRTX, release date:May 10, 2018
Biotech Analysis Central Pharma News: Takeda's Acquisition Win, Ionis And Akcea Tumble, Alnylam's Advance In CNS https://seekingalpha.com/article/4171591-biotech-analysis-central-pharma-news-takedas-acquisition-win-ionis-akcea-tumble-alnylams?source=feed_sector_healthcare May 09, 2018 - Takeda Acquires Shire for $62 billion.Ionis and Akcea face a major safety issue with volanesoren, which is expected to be up for FDA panel review in the coming days.Alnlylam shows proof of concept tha
Vanguard Health Care Reduces Abbott, Bristol-Myers Positions http://www.gurufocus.com/news/678701/vanguard-health-care-reduces-abbott-bristolmyers-positions May 08, 2018 - Vanguard Health Care Reduces Abbott, Bristol-Myers Positions, Stocks: MRK,VRTX,ABT,BMY,LLY,HCA,CERN, Vanguard Health Care Fund, release date:May 08, 2018
Institutional Top Ideas Series: Orbimed Advisors https://seekingalpha.com/article/4169731-institutional-top-ideas-series-orbimed-advisors?source=feed_all_articles May 04, 2018 - Today's fund in the spotlight, Orbimed Advisors, is quite large and in the midst of a leadership transition. They avoid outsized bets (over 5% weighting) yet still post decent returns.I provide a brie
De Burlo Group Inc Buys Red Hat Inc, Palo Alto Networks Inc, MKS Instruments Inc, Sells ... http://www.gurufocus.com/news/676290/de-burlo-group-inc-buys-red-hat-inc-palo-alto-networks-inc-mks-instruments-inc-sells-alphabet-inc-avery-dennison-corp-owenscorning-inc May 03, 2018 - De Burlo Group Inc Buys Red Hat Inc, Palo Alto Networks Inc, MKS Instruments Inc, Sells Alphabet Inc, Avery Dennison Corp, Owens-Corning Inc, Stocks: RHT,MKSI,ADBE,VRTX,EW,SIVB,PANW,PAYC,SHOP,VEEV,ETF, release date:May 03, 2018
The Old Faithful Portfolio https://seekingalpha.com/article/4168403-old-faithful-portfolio?source=feed_tag_etf_portfolio_strategy May 02, 2018 - By Gautam Dhingra, PhD, CFA and Christopher J. Olson, CFA Old Faithful is the most famous geyser in Yellowstone National Park, having earned its name because of the extraordinary reliability of its sp

Pages: 123456...31

Page 1>
DeepLinks for Vertex Pharmaceuticals Incorporated
VRTX - Google Finance https://www.google.com/finance?q=VRTX Industry related info and international coverage Summary News
VRTX - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=VRTX Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options